Latest statistics and disclosures from Abingworth's latest quarterly 13F-HR filing:
- Top 5 stock holdings are Paratek Pharmaceuticals, Proteon Therapeutics, Sientra, Tobira Therapeutics Inc Common Stock Usd 0.0001, Cempra. These five stock positions account for 65.49% of Abingworth's total stock portfolio.
- Added to shares of these 3 stocks: Senseonics Hldgs, Immune Design, Aurinia Pharmaceuticals.
- Started 3 new stock positions in Senseonics Hldgs, Aurinia Pharmaceuticals, Immune Design.
- Reduced shares in these 1 stocks: .
- Sold out of its positions in Chemocentryx.
- As of June 30, 2016, Abingworth has $95.50M in assets under management (AUM). Assets under management dropped from a total value of $165.70M to $95.50M.
- Independent of market fluctuations, Abingworth was a net buyer by $3.28M worth of stocks in the most recent quarter.
Abingworth portfolio companies for June 2016 quarter
|Company (Ticker)||Portfolio Weight||Share Count||Price||Last Trade|
|Tobira Therapeutics Inc Common Stock Usd 0.0001||7.73||589244||12.52||0.00|
|Cellectis S A sponsored ads||2.78||100000||26.59||0.00|
|Senseonics Hldgs||2.12||516882 NEW||3.92||0.00|
|Immune Design||1.69||197300 NEW||8.16||0.00|
|Aurinia Pharmaceuticals||1.45||512036 NEW||2.71||0.00|
|OncoGenex Pharmaceuticals (OGXI)||0.42||396104||1.01||2.23|
|Epirus Biopharmaceuticals In||0.00||7896||0.51||0.00|
Past 13F-HR SEC Filings for Abingworth
- Abingworth 2015 Q4 filed Feb. 16, 2016
- Abingworth 2015 Q3 filed Nov. 13, 2015
- Abingworth 2014 Q4 filed Feb. 13, 2015
- Abingworth 2014 Q3 amended filed Nov. 25, 2014
- Abingworth 2014 Q1 filed May 21, 2014
- Abingworth 2013 Q2 filed Aug. 14, 2013
- Abingworth 2013 Q1 filed May 15, 2013
- Abingworth 2012 Q4 filed Feb. 13, 2013
- Abingworth 2012 Q3 filed Nov. 7, 2012
- Abingworth 2012 Q1 filed May 14, 2012
- Abingworth 2011 Q4 filed Feb. 7, 2012
- Abingworth 2011 Q3 filed Nov. 14, 2011
- Abingworth 2011 Q1 filed May 13, 2011
- Abingworth 2010 Q4 filed Feb. 14, 2011